🔗 Share this article

The top legal official in Texas Paxton is filing a lawsuit against the producers of acetaminophen, alleging the companies hid safety concerns that the medication presented to pediatric cognitive development.

The court filing comes four weeks after Donald Trump advocated an unsubstantiated connection between taking Tylenol - referred to as paracetamol - throughout gestation and autism spectrum disorder in children.

The attorney general is taking legal action against Johnson & Johnson, which previously sold the drug, the exclusive pain medication recommended for women during pregnancy, and the current manufacturer, which now manufacturers it.

In a statement, he stated they "misled consumers by making money from suffering and promoting medication ignoring the potential hazards."

The manufacturer says there is lacking scientific proof connecting Tylenol to autism spectrum disorder.

"These manufacturers deceived for years, intentionally threatening numerous people to increase profits," the attorney general, a Republican, stated.

The manufacturer stated officially that it was "deeply concerned by the spread of false claims on the security of acetaminophen and the possible consequences that could have on the health of American women and children."

On its website, Kenvue also mentioned it had "regularly reviewed the pertinent research and there is insufficient valid information that indicates a proven link between consuming paracetamol and autism spectrum disorder."

Groups acting on behalf of medical professionals and medical practitioners agree.

ACOG has declared acetaminophen - the key substance in Tylenol - is among limited choices for pregnant women to address discomfort and fever, which can create major wellness concerns if not addressed.

"In more than two decades of studies on the consumption of acetaminophen in pregnancy, zero credible investigations has conclusively proven that the usage of paracetamol in any trimester of gestation causes neurological conditions in children," the organization said.

The court filing mentions current declarations from the previous government in arguing the drug is potentially dangerous.

Last month, Trump generated worry from health experts when he instructed expectant mothers to "resist strongly" not to use Tylenol when ill.

The FDA then issued a notice that medical professionals should consider limiting the use of acetaminophen, while also stating that "a proven link" between the drug and autism in children has remains unverified.

The Health Department head Kennedy, who oversees the FDA, had promised in April to conduct "a massive testing and research effort" that would determine the source of autism spectrum disorder in a short period.

But experts warned that identifying a unique factor of autism spectrum disorder - believed by scientists to be the result of a intricate combination of genetic and surrounding conditions - would not be simple.

Autism is a category of enduring cognitive variation and condition that influences how people experience and interact with the world, and is identified using physician assessments.

In his lawsuit, the attorney general - who supports Trump who is campaigning for US Senate - claims Kenvue and Johnson & Johnson "deliberately disregarded and tried to quiet the research" around acetaminophen and autism spectrum disorder.

The case attempts to require the firms "destroy any marketing or advertising" that asserts Tylenol is secure for expectant mothers.

This legal action echoes the concerns of a group of guardians of young ones with autism spectrum disorder and attention deficit hyperactivity disorder who sued the producers of Tylenol in recently.

A federal judge dismissed the case, stating investigations from the family's specialists was inconclusive.